Indicaton
Regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (COVID-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19
- Leave a review
- Bookmark
- Share
- Report
- prev
- next
Company
Table
-
PhaseMarketed
-
Partnering statusPartnered
-
PartnerCelltrion
-
Available inSwitzerland
You may also be interested in
Cadazolid 
-
Crohn's disease
Phase II started
Zevtera / Mabelio (ceftobiprole)
-
Acute bacterial skin and skin structure infections (ABSSSI)
Phase III completed
Zevtera / Mabelio (ceftobiprole)
-
Staphylococcus aureus bacteremia
Phase III completed